Affymetrix to Acquire Neomorphic for $70M | GenomeWeb

NEW YORK, Oct. 2 – GeneChip-maker Affymetrix (Nasdaq: AFFX) of Santa Clara Calif., said Monday that it would acquire privately-held computational genomics company Neomorphic of Berkeley, Calif., for about $70 million in stock, based on Friday’s close.

The companies anticipate that products resulting from the acquisition will include whole-genome, high-density GeneChip arrays, new data analysis tools, and a series of Internet-accessible information products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.